演讲者

 

  •  Derek Abbott, Ph.D., Director, Analytics, Amyris, Inc. 
  •  Sreedhara Alavattam, Ph.D., Principal Scientist and Senior Group Leader, Genentech, Inc.
  •  Alina Alexeenko, Ph.D., Professor, School of Aeronautics and Astronautics, Purdue University 
  •  Afreen Allam, MBA, CEO & President, SiNON Therapeutics 
  •  Arun Alphonse Ignatius, Ph.D., Principal Scientist, Pfizer 
  •  Richard Altman, MS, Scientist, Protein Technologies, Amgen 
  •  Philip An, Scientist, Biologics, Amgen 
  •  Mark Arbing, Ph.D., Core Facility Director, UCLA-DOE Institute, University of California, Los Angeles
  •  Frederick Arce-Vargas, M.D., Ph.D., Research Associate, University College London Cancer Institute, United Kingdom 
  •  Juan Aon, Ph.D., Senior Manager, MCCD, RD Biopharm, R&D, GSK 
  •  Paul Armistead, M.D., Ph.D., Associate Professor, Medicine, Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill 
  •  Yun Bai, Ph.D., Director, Ambrx, Inc. 
  •  Ramesh Baliga, Ph.D., Vice President, Discovery Biology, IGM Biosciences 
  •  Sashikanth Banappagari, Ph.D., Scientist II, Formulation Development, Vaccine Production Program/VRC/NIAID/NIH 
  •  Scott Banta, Ph.D., Professor, Chemical Engineering, Columbia University 
  •  Yoram Barak, Ph.D., Biosciences Innovation Manager, BASF Enzymes, LLC 
  •  Gavin Barnard, Ph.D., Group Leader, Biotechnology Discovery Research, Eli Lilly and Company 
  •  Nicola Beaucamp, Ph.D., Head, Process Research, Pharma Research and Early Development, Roche Innovation Center Munich, Roche Diagnostics GmbH 
  •  Jared Bee, Ph.D., Senior Scientist, Analytical Development Group Leader, MacroGenics, Inc. 
  •  Stephen Beers, Ph.D., Associate Professor, Cancer Immunology and Immunotherapy, University of Southampton, United Kingdom 
  •  Robert D. Bell, Ph.D., Senior Principal Scientist, Neurovascular Biology Lab Head, Pfizer, Inc. 
  •  Frank Bernhard, Ph.D., Lab Leader, Institute of Biophysical Chemistry, Goethe University Frankfurt 
  •  Akhilesh Bhambhani, Ph.D., Principal Scientist & Group Leader, New Technologies-Vaccine Drug Product Development, Merck & Co., Inc. 
  •  Jean-Marc Bielser, MSc, Research Scientist, Biopharma Technology and Innovation, EMD Serono 
  •  David Bienvenue, Senior Director, Protein Sciences, Aptevo Therapeutics 
  •  Uli Binde, Ph.D., CTO, XL-Protein 
  •  Joerg Birkenfeld, Ph.D., Section Head, High Throughput Biologics, R&D Biologics Research/Protein Therapeutics, Sanofi-Aventis Deutschland GmbH 
  •  Ruben Boado, Ph.D., Vice President, Research & Development/Co-Founder, ArmaGen, Inc. 
  •  Christopher Boddy, Ph.D., Professor & Director, Biochemistry Program, University of Ottawa 
  •  Berthold Boedeker, Ph.D., Chief Scientist, Global Biologics Development, Bayer Pharma AG 
  •  Jonathan Bones, Ph.D., Principal Investigator, Characterisation and Comparability Laboratory, National Institute for Bioprocessing Research and Training 
  •  Andrew Bradbury, Ph.D., CSCO, Specifica, Inc.
  •  David Bramhill, Ph.D., Founder, Bramhill Biological Consulting, LLC 
  •  Christoph Brandenbusch, Ph.D., Group Leader, Biochemical and Chemical Engineering, Technical University, Dortmund, Germany 
  •  Juma Bridgewater, Ph.D., Senior Scientist, Analytical Sciences and Technology, Bristol-Myers Squibb 
  •  Ulrich Brinkmann, Ph.D., Expert Scientist, Scientific Director, Roche Pharma Research & Early Development, Roche Innovation Center Munich 
  •  William Callahan, Senior Scientist, Amgen 
  •  Julio A. Camarero, Ph.D., Professor, Pharmacology and Pharmaceutical Sciences, School of Pharmacy, University of Southern California 
  •  Marie Caparon, Ph.D., Associate Research Fellow, Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc.
  •  Paul J. Carter, Ph.D., Staff Scientist and Senior Director, Antibody Engineering, Genentech, Inc. 
  •  Mauro Castellarin, Ph.D., Postdoctoral Researcher, Center for Cellular Immunotherapies, University of Pennsylvania School of Medicine 
  •  Steven Chamow, Ph.D., Principal Consultant, Chamow & Associates, Inc. 
  •  Zhilei Chen, Ph.D., Associate Professor, Microbial Pathogenesis and Immunology, Texas A&M College of Medicine 
  •  David Chiu, Ph.D., Scientist, Analytical Sciences, Seattle Genetics 
  •  Yongku Cho, Ph.D., Assistant Professor, Chemical and Biomolecular Engineering, University of Connecticut 
  •  Partha Chowdhury, Ph.D., Senior Director and Head, Antibody Discovery, Sanofi Genzyme 
  •  Marcus T. Cicerone, Ph.D., Biomaterials Group, National Institute of Standards and Technology 
  •  Jeannick Cizeau, Ph.D., Director, Research, Viventia Bio, Inc 
  •  Bernardo Cordovez, President, Halo Labs 
  •  Gregory Daniels, M.D., Ph.D., Professor, Medicine, Moores Cancer Center, University of California, San Diego 
  •  Rebecca Davis-Harrison, Ph.D., Research Scientist, BioTechnology Discovery Research, Eli Lilly and Company 
  •  Kangwen Deng, Ph.D., Senior Scientist, Biologics, AbbVie 
  •  Mehabaw G. Derebe, Ph.D., Scientist, Biologics Engineering, Janssen BioTherapeutics 
  •  Jason DeVoss, Ph.D., Senior Scientist, Oncology, Amgen 
  •  Craig D. Dickinson, Ph.D., Senior Research Advisor, AME, Eli Lilly and Company 
  •  Gundo Diedrich, Ph.D., Associate Director, Antibody Engineering, MacroGenics, Inc. 
  •  Dimiter S. Dimitrov, Ph.D., Senior Investigator, Protein Interactions Section, Cancer and Inflammation Program, National Cancer Institute, NIH 
  •  Rakesh Dixit, Ph.D., DABT, Vice President, R&D, MedImmune/AstraZeneca 
  •  Robert Dream, Ph.D., Managing Director, HDR Company LLC 
  •  Andre C. Dumetz, Ph.D., Senior Scientific Investigator, Biopharm Downstream PD-3, R&D Platform Technology & Science, GlaxoSmithKline 
  •  Jiali Du, Ph.D., Scientist, Formulation Sciences, MedImmune 
  •  Joseph Duque, Senior Scientist, Merck Research Laboratories
  •  Mike Dyson, Ph.D., CTO, IONTAS, Ltd. 
  •  Adam Elhofy, Ph.D., CSO, Essential Pharmaceuticals 
  •  Diego Ellerman, Ph.D., Principal Scientific Researcher, Genentech, Inc. 
  •  Mark Ellis, Principal Scientist, Protein Expression and Purification, UCB Pharma 
  •  Sam Ellis, Vice President, Thomson Instrument Company 
  •  Dominic Esposito, Ph.D., Director, Protein Expression Laboratory, Frederick National Laboratory for Cancer Research 
  •  Adam Feist, Ph.D., Project Scientist, Systems Biology Research Group, University of California 
  •  Timothy Fenn, Ph.D., Principal Scientist, Boehringer Ingelheim 
  •  Vasco Filipe, Ph.D., Lab Head, Pharmaceutical Development Biologics, Sanofi 
  •  Nicolas Fischer, Ph.D., Head, Research, Novimmune SA, Switzerland 
  •  Heather Flores, BS, Scientist, Technical Development Scientist, Late Stage Pharmaceutical Development, Genentech, Inc. 
  •  Soren Flygenring Basset, Ph.D., Director, R&D, Novo Nordisk Pharmatech A/S 
  •  Bjorn Frendeus, Ph.D., CSO, Bioinvent, Sweden 
  •  Per-Ola Freskgard, Ph.D., Vice Director and Senior Leader, Neuroscience, Roche Innovation Center Basel, F. Hoffmann-La Roche Ltd. 
  •  Douglas Fuerst, Ph.D., Director, GSK Fellow, Advanced Manufacturing Technologies, GlaxoSmithKline 
  •  Julia Gavrilyuk, Ph.D., Principal Research Scientist, Chemistry Lead, Discovery Chemistry, Abbvie StemcentRx, Inc. 
  •  Raja Ghosh, Ph.D., Professor and Canada Research Chair, Bioseparations Engineering, Chemical Engineering, McMaster University 
  •  Henning Gieseler, Ph.D., CSO, Pharmaceutical Development, GILYOS GmbH 
  •  Ryan T. Gill, Ph.D., Slade Professor, Chemical and Biological Engineering, University of Colorado 
  •  Pierre-Alain Girod, CSO, Selexis 
  •  Adam Goldstein, MSc, Principal Scientist, Global Technology, Roche/Genentech 
  •  Christoph Goletz, Associate Director, Immunomodulation, Glycotope GmbH 
  •  Christopher H. Gray, Ph.D., Team Leader, Structural Biology, Drug Discovery Program, CRUK Beatson Institute 
  •  Karl E. Griswold, Ph.D., Associate Professor, Thayer School of Engineering, Dartmouth College 
  •  Flaviu Gruia, Ph.D., Principal Scientist, Drug Product Analytical Development, Moderna Therapeutics 
  •  Jijie Gu, Ph.D., Research Fellow and Function Head, Immunology Discovery, AbbVie Bioresearch Center 
  •  Rudiyanto Gunawan, Ph.D., Assistant Professor, Institute for Chemical and Bioengineering, ETH Zurich 
  •  Kapil Gupta, Ph.D., Associate Director, Protein Pharmaceutical Development, Biogen 
  •  Claes Gustafsson, CCO & Founder, ATUM (formerly DNA2.0) 
  •  Shiang Gwee, Scientist, Drug Product Sciences, MacroGenics, Inc. 
  •  Andrew Holloway, Senior Research Associate, Analytical Sciences, Seattle Genetics, Inc. 
  •  Amy Han, Ph.D., Director, Chemistry, Regeneron Pharmaceuticals
  •  Brian Hall, Ph.D., Principal Scientist, Biologics, Merck & Co. 
  •  Christian Harding, Ph.D., CSO, VaxNewMo 
  •  Feras Hatahet, Ph.D., Biologics Discovery, Amgen 
  •  Cheng Her, Ph.D., Postdoctoral Research Fellow, Carpenter Lab, Pharmaceutical Sciences, University of Colorado-Denver, Anschutz Medical Campus 
  •  Robert Herbst, Ph.D., Director, Process Development and Engineering, ImmunoGen, Inc. 
  •  Mark Hildebrand, Ph.D., Research Scientist and Director, Marine Biology Research Division, Scripps Institution of Oceanography, University of California, San Diego 
  •  Oliver Hill, Ph.D., Vice President, Molecular Biology/Protein Engineering, Apogenix AG 
  •  Sophia Hober, Ph.D., Professor, Molecular Biotechnology, KTH Royal Institute of Technology 
  •  Desmond G. Hunt, Ph.D., Senior Scientific Liaison, Standards Development, United States Pharmacopeia (USP) 
  •  Farren Isaacs, Ph.D., Assistant Professor, Molecular Cellular and Development Biology, Yale University 
  •  Jorge Ivan Alvarez, Ph.D., Assistant Professor, Department of Pathobiology, University of Pennsylvania 
  •  Lavanya Iyer, Ph.D., Research Investigator, Bristol-Myers Squibb
  •  Renaud Jacquemart, Ph.D., BioPharma Downstream Process Specialist, Natrix Separations 
  •  Jacob Janey, Ph.D., Associate Director, BMS 
  •  Miroslaw Janowski, M.D., Ph.D., Associate Professor, Radiology, Johns Hopkins University
  •  Donald L. Jarvis, Ph.D., Professor, Molecular Biology, University of Wyoming 
  •  Haiyan Jiang, Ph.D., Principal Scientist, Biologics Research, Janssen BioTherapeutics, Janssen R&D 
  •  Xin Jiang, Product Marketing Manager, ProteinSimple 
  •  Nathan H. Joh, Ph.D., Scientist, Attribute Sciences, Amgen 
  •  Aled Jones, Senior Product and Applications Manager, ProZyme 
  •  John Kawooya, Ph.D., Director, Biologics Optimization, Amgen 
  •  Sagar Kathuria, Ph.D., Senior Scientist, Protein Engineering, Sanofi Genzyme 
  •  Alex Kelly, Business Development Manager, Retrogenix Limited 
  •  Eric Kelsic, Ph.D., Staff Scientist, George Church Laboratory, Wyss Institute, Harvard Medical School 
  •  Kristin Kemmerich, Ph.D., Head, Antibody Generation Section, National Research Council Canada 
  •  Christopher Kemp, Ph.D., President, Kempbio 
  •  Sophia Kenrick, Ph.D., Senior Applications Scientist, Wyatt Technology 
  •  Tarik Khan, Ph.D., Group Leader, Late-Stage Pharmaceutical and Processing Development, F. Hoffmann-La Roche Ltd., Switzerland 
  •  Maura Kibbey, Ph.D., Director, Global Biologics, U.S. Pharmacopeia 
  •  Takanori Kigawa, Ph.D., Team Leader, Quantitative Biology Center, RIKEN 
  •  Yoshimi Kikuchi, Ph.D., Executive Professional and Group Manager, Recombinant Protein Research Group, Material Development & Application Labs, Ajinomoto Co., Inc. 
  •  Philip M. Kim, Ph.D., Associate Professor, Computational and Integrative Biology, University of Toronto, Canada 
  •  Yong-Sung Kim, Ph.D., Professor, Molecular Science and Technology, Ajou University, Korea 
  •  Jonathan S. Kingsbury, Ph.D., Principal Scientist, Global Pharmaceutical Development Biologics, Sanofi 
  •  Marina Kirkitadze, Ph.D., Deputy Director, Head of Biophysics and Conformation Unit, Analytical R&D Biochemistry, Sanofi Pasteur, Canada 
  •  Georg Klima, Dipl. Ing., Executive Director, Process Science, Boehringer Ingelheim RCV GmbH & Co. KG 
  •  Manfred Konrad, Ph.D., Research Director, Enzyme Biochemistry, Max Planck Institute for Biophysical Chemistry 
  •  Marie Kosco-Vilbois, Ph.D., CSO, NovImmune SA 
  •  Thomas E. Kraft, Ph.D., Postdoctoral Scientist, Large Molecule Research, Roche Diagnostics GmbH 
  •  Simon Krah, Ph.D., Senior Scientist, Protein Engineering and Antibody Technologies, Merck KGaA, Germany 
  •  Claus Kristensen, Ph.D., CEO, GlycoDisplay Aps
  •  Yoichi Kumada, Dr. Eng., Associate Professor, Kyoto Institute of Technology 
  •  Steven LaBrenz, Ph.D., Scientific Director, Cell and Developability Sciences, PDMS, Janssen R&D 
  •  Eilyn R. Lacy, Ph.D., Principal Scientist, Janssen BioTherapeutics (JBIO), Janssen Research & Development, LLC 
  •  James Lalonde, Ph.D., Senior Vice President, R&D, Codexis 
  •  Lois A. Lampson, Ph.D., Emeritus Associate Professor of Neurosurgery, Brigham & Women's Hospital/Harvard Medical School 
  •  Olga S. Latinovic, Ph.D., Assistant Professor and Head, Lab for Imaging Studies of Pathogens & Cell Interactions and IHV Imaging Facility, Institute of Human Virology and Microbiology and Immunology, University of Maryland  School of Medicine 
  •  Thomas Laue, Ph.D., Professor Emeritus, Molecular, Cellular and Biomedical Sciences, University of New Hampshire 
  •  Gyun Min Lee, Ph.D., Professor, Biological Sciences, KAIST 
  •  Jonas Lee, Ph.D., Scientist, Amgen 
  •  Toni Lee, Ph.D., Senior Scientist, Biocatalysis, Provivi 
  •  Ming Lei, Ph.D., Senior Research Associate, Protein Analytical Chemistry, Genentech 
  •  Nathan E. Lewis, Ph.D., Assistant Professor, Department of Pediatrics, University of California, San Diego 
  •  Kim Li, Ph.D., DABT, MPH, Senior Manager, Environment, Health, Safety and Sustainability Product Stewardship Toxicology, Amgen 
  •  John Lofblom, Ph.D., Associate Professor, Protein Technology, Biotechnology, KTH Royal Institute of Technology 
  •  Urs Lohrig, Ph.D., Labhead, Phys. Chem. Characterization, Biosimilars, Biologics Technical Development & Manufacturing, Sandoz GmbH 
  •  Thorsten Lorenz, Ph.D., Group Head, Developability Assessment, Integrated Biologics Profiling, Novartis Pharma AG 
  •  Nikolai Lorenzen, Ph.D., Large Protein Biophysics, Novo Nordisk A/S 
  •  Xiaofeng Lu, Ph.D., Principal Research Scientist, Pharmaceutical Development, AbbVie, Inc. 
  •  Haibin Luo, Ph.D., Scientist II, MedImmune LLC 
  •  Jacob Luoma, Engineer II, Pharmaceutical Processing and Technology Development, Genentech 
  •  Stefan Lutz, Ph.D., Professor and Department Chair, Department of Chemistry, Emory University
  •  Haripada Maity, Ph.D., Research Advisor, Formulation Development, CMC Development, Eli Lilly and Company 
  •  Anne Marcil, Team Lead, Monoclonal Antibodies, National Research Council, Canada 
  •  Allan Matte, Ph.D., Senior Research Officer, Downstream Processing & Analytics, Human Health Therapeutics, National Research Council Canada (NRC-CNRC) 
  •  Kevin Mattison, Principal Scientist, Bioscience, Malvern PANalytical 
  • John McCafferty, Ph.D., CEO, Antibody Engineering, IONTAS, Ltd. 
  • Karen McDonald, Ph.D., Professor, Chemical Engineering, University of California, Davis 
  • Kathryn A. McGohan, MS, Associate Scientist II, Manufacturing Sciences and Technology, Materials Science, Bristol-Myers Squibb Co. 
  • Colin Medley, Ph.D., Senior Scientist, Small Molecule Pharmaceutical Sciences, Genentech, Inc.
  • Torben Moos, M.D., Ph.D., DMSc, Professor, Medicine and Health Technology, Aalborg University 
  •  Charles Moore, Ph.D., Research Investigator, Novartis 
  •  Kendall Morrison, Ph.D., Director, Protein Technologies, Agensys, Inc. (an affiliate of Astellas Pharma) 
  •  Phil Morton, Ph.D., Science Director, Bioprocess Characterisation, Albumedix 
  •  Eric J. Munson, Ph.D., Patrick DeLuca Endowed Professor, Department of Pharmaceutical Sciences, College of Pharmacy, University of Kentucky 
  •  Yasser Nashed-Samuel, Ph.D., Principal Scientist, Attribute Sciences, Process Development, Amgen 
  •  Madhu Natarajan, Ph.D., Preclinical Therapeutic Area Head, Ophthalmology & Complement Biology, Shire 
  •  Peter Neubauer, Ph.D., Professor, Department of Bioprocess Technology, Institute of Biotechnology, Technische Universitat Berlin 
  •  Juergen Nett, Ph.D., Director, High Throughput Expression, Adimab, LLC 
  •  Dennis Niermeier, MSc, IBA Lifesciences 
  •  Vaheh Oganesyan, MS, Scientist, MedImmune 
  •  Adekunle O. Onadipe, Ph.D., Associate Research Fellow, Cell Line Development, Bioprocess R&D, Pfizer 
  •  Marcin Paduch, Ph.D., Pipeline Director, Recombinant Antibody Network, University of Chicago 
  •  Tadas Panavas, Ph.D., Associate Director, Discovery Research, Alexion Pharmaceuticals 
  •  Dimitris Papamichail, Ph.D., Assistant Professor, Computer Science, The College of New Jersey
  •  Niv Papo, Ph.D., Group Leader and Assistant Professor, Biotechnology Engineering, Ben-Gurion University 
  •  Diane Paskiet, MS, Director of Scientific Affairs, Scientific Affairs and Technical Services, West Pharmaceutical Services 
  •  Edward F. Patz, Jr., M.D., Professor, Radiology, Pharmacology and Cancer Biology Duke University Medical Center 
  •  Li Peng, Ph.D., Vice President, Antibody Engineering and Protein Sciences, Palleon Pharmaceuticals 
  •  Robert Pejchal, Ph.D., Scientist, Antibody Engineering, Adimab LLC
  •  Robert Peters, Ph.D., Senior Vice President, Research, Bioverativ, Inc. 
  •  Didier Pertuy, Vice President, Global Drug Device Integrated Development & Device Strategy, Sanofi, France 
  •  Samuel Pollock, Researcher, Pharmaceutical Chemistry, University of California, San Francisco 
  •  Dennis Powers, Director, Sales Engineering, G-CON Manufacturing 
  •  James R. Prudent, Ph.D., President & CEO, Centrose LLC 
  •  Enrico Purisima, Ph.D., Team Leader, Molecular Modeling, National Research Council Canada 
  •  Wei Qi, Ph.D., Scientist, Pre-Pivotal Drug Product, Amgen 
  •  Laszlo Radvanyi, Ph.D., Senior Vice President, Senior Scientific Advisor, Immunology, Immuno-Oncology, EMD Serono R&D Institute (a business of Merck KGaA, Darmstadt, Germany) 
  •  Czeslaw Radziejewski, Ph.D., Senior Principal Research Scientist, Biophysical Chemistry, AbbVie 
  •  Smita Raghava, Ph.D., Senior Scientist, Sterile Formulation Sciences, Merck & Co.
  • G. Jonah Rainey, Ph.D., Executive Director, Research, MabVax Therapeutics Holdings, Inc. 
  •  Alexey Rak, Ph.D., Head of Bio Structure and Biophysics, Integrated Drug Discovery, Sanofi R&D 
  •  Srivatsan Raman, Ph.D., Assistant Professor, Departments of Biochemistry & Bacteriology, University of Wisconsin-Madison 
  •  Servio Ramirez, Ph.D., Associate Professor, Pathology and Laboratory Medicine, Lewis Katz School of Medicine, Temple University 
  •  Theodore W. Randolph, Ph.D., Kenneth and Genevieve Gillespie Professor, Department of Chemical and Biological Engineering, University of Colorado, Boulder 
  •  Helen Rawsthorne, Ph.D., Senior Research Scientist, Molecular Biology and Fermentation, Albumedix 
  •  Wayne F. Reed, Ph.D., Professor, Physics, Tulane University 
  •  Christoph Reese, Ph.D., Director, Microbial Fermentation, Roche Diagnostics GmbH 
  •  Dorothea Reilly, Ph.D., Principle Scientist and Associate Director, Early Stage Cell Culture, Genentech 
  •  Nigel F. Reuel, Ph.D., Assistant Professor, Chemical and Biological Engineering, Iowa State University 
  •  Joel Richard, Ph.D., Vice President, Peptides, CMC & Engineering, Ipsen 
  •  Gabriel Rocklin, Ph.D., Senior Fellow, Biochemistry & Bioengineering, University of Washington 
  •  Miguel Angelo Rodrigues, Ph.D., Researcher and Invited Professor, Chemical Engineering, Instituto Superior Tecnico, University of Lisbon 
  •  Floyd Romesberg, Ph.D., Professor, Chemistry, The Scripps Research Institute 
  •  Alice Rothnie, D.Phil., Lecturer, Biochemistry, Life & Health Sciences, Aston University 
  •  David Rozzell, Ph.D., Senior Vice President, Biocatalysis, Provivi 
  •  Kevin Rust, Ph.D., Principal Scientist, Bioprocess R&D, BioTherapeutics Pharmaceutical Sciences, Pfizer, Inc. 
  •  Natalie Saez, Ph.D., Senior Research Officer, Institute for Molecular Bioscience, The University of Queensland 
  •  Miguel Saggu, Scientist, Late Stage Pharmaceutical Development, Genentech 
  •  Andrey G. Sarafanov, Ph.D., Chemist, Principal Investigator, Center for Biologics Evaluation and Research, U.S. Food and Drug Administration (FDA) 
  •  Prasad Sarangapani, Ph.D., Staff Scientist, Protein Biochemistry, Regeneron Pharmaceuticals 
  •  Jonas Schaefer, Ph.D., Head, High-Throughput Binder Selection Facility, Biochemistry, University of Zurich 
  •  Volker Schellenberger, Ph.D., President and CEO, Amunix 
  •  Tilman Schlothauer, Ph.D., Principal Scientist, Biochemical and Analytical Research, Large Molecule Research, Roche Innovation Center Munich 
  •  Stefan Schmidt, Ph.D., MBA, CSO, Development and Innovation, Rentschler Biotechnology 
  •  Christian Schoneich, Ph.D., Distinguished Professor and Chair, Pharmaceutical Chemistry, University of Kansas 
  •  Ian Schwartz, MS, CMC Expert, Antibody Drug Conjugate and Upstream/Downstream Process Development, Tech Transfer, and Manufacturing Ops, Sartorius Stedim Biotech 
  •  Sebastian Schuck, Ph.D., Head, Business Development, Wacker Biotech GmbH 
  •  Carolin Sellmann, Ph.D., Scientist, Protein Engineering and Antibody Technologies, Merck KGaA 
  •  Saurabh Sen, Ph.D., Principal Scientist, Biotherapeutics Discovery, Boehringer Ingelheim 
  •  Justin Siegel, Ph.D., Assistant Professor, Biochemistry & Molecular Medicine, UC Davis Genome Center 
  •  Michael Sierks, Ph.D., Professor, Chemical Engineering, Arizona State University 
  •  Michael Siedler, Ph.D., Head, NBE High-Throughput and Advanced Formulation Sciences, Drug Product Development, AbbVie Deutschland GmbH & Co. KG 
  •  Ian Shieh, Ph.D., Scientist, Genentech 
  •  Judy Shimoni, Ph.D., Principal Scientist and Group Leader, Protein Analytical Chemistry, Genentech, Inc., a member of the Roche Group 
  •  Christopher Smith, Ph.D., Senior Scientific Consultant, Biologics, Genedata 
  •  Eric Smith, Ph.D., Director, Bispecific Antibdies, Regeneron Pharmaceuticals, Inc. 
  •  Chris Spahr, Senior Scientist, Therapeutic Discovery, Discovery Attribute Sciences, Amgen, Inc. 
  •  Jason Stewart, BS, Senior Associate Scientist, Pharmaceutical Research and Development, Pfizer, Inc. 
  •  Lars Stockl, Ph.D., Director, Glycoprotein Development and PTM Analytics, Glycotope GmbH 
  •  Kevin Strozyk, Sr. Research Associate, Analytical Sciences, Seattle Genetics 
  •  Shanmuuga T. Sundaram, Ph.D., Research Advisor, BioAnalytical Sciences, Bioproduct Research and Development, Eli Lilly and Company 
  •  David E. Szymkowski, Ph.D., Vice President, Cell Biology, Xencor, Inc. 
  •  Saurabh Sen, Ph.D., Principal Scientist, Biotherapeutics Discovery, Boehringer Ingelheim 
  •  Feng Shu, Ph.D., Senior Researcher, Chugai Pharmabody Research, Singapore 
  •  Ken Skidmore, Technical Development Scientist, Protein Analytical Chemistry, Genentech 
  •  Michael Swanson, Ph.D., Senior Scientist, Merck 
  •  Rastislav Tamaskovic, Ph.D., Senior Scientist, Biochemistry, University of Zurich 
  •  Jamshid Tanha, Ph.D., Senior Research Officer, Human Health Therapeutics Portfolio, National Research Council Canada 
  •  Hanna Tegel, Ph.D., Scientist and Group Leader, Biotechnology, Proteomics and Nanobiotechnology, KTH Royal Institute of Technology 
  •  Devin Tesar, Ph.D., Scientist, Drug Delivery, Genentech 
  •  Holger Thie, Ph.D., Associate Director, Molecular Biology, Early Stage Bioprocess Development, Boehringer Ingelheim Pharma GmbH & Co. KG 
  •  Mihriban Tuna, Ph.D., Vice President, Drug Discovery, F-star Biotechnology, Ltd. 
  •  Jonas Hoeg Thygesen, Ph.D., Area Specialist, R&D - Microanalysis Centre, Novo Nordisk Pharmatech 
  •  Elizabeth M. Topp, Ph.D., Dane O. Kildsig Chair and Department Head, Department of Industrial and Physical Pharmacy, Purdue University 
  •  Riccardo Torosantucci, Ph.D., Head of Laboratory Formulation Development, Pharmaceutical Development Biologics, Sanofi-Aventis Deutschland GmbH 
  •  Nicholas Turner, Ph.D., Professor, Chemical Biology, University of Manchester 
  •  Thomas J. Van Blarcom, Ph.D., Associate Research Fellow, Rinat Laboratories, Oncology Research and Development, Pfizer, Inc. 
  •  Ewald Van den Bremer, Ph.D., Senior Scientist, Genmab A/S 
  •  Floris Van Delft, Ph.D., Founder & CSO, SynAffix BV 
  •  James Van Deventer, Ph.D., Assistant Professor, Chemical and Biological Engineering, Tufts University 
  •  Dmitry G. Vassylyev, Ph.D., Professor, Biochemistry and Molecular Genetics, University of Alabama at Birmingham 
  •  Pandurangan Vijayanand, M.D., Ph.D., Associate Professor, Vaccine Discovery, La Jolla Institute for Allergy and Immunology 
  •  Bjorn Voldborg, Director, CHO Cell Line Development, The Novo Nordisk Foundation Center for Biosustainability, Technical University of Denmark 
  •  Moritz Von Stosch, Ph.D., Senior Manager, Fermentation, Technical R&D, GSK Vaccines 
  •  Jonathan Wall, Ph.D., Professor and Director, Amyloidosis and Cancer Theranostics Program, University of Tennessee Medical Center 
  •  Frank S. Walsh, Ph.D., CEO, Ossianix 
  •  Ping Wang, Ph.D., Principal Scientist and Senior Manager, Janssen R&D, a Pharmaceutical Company of Johnson & Johnson 
  •  Tianyi Wang, Ph.D., Scientist, R&D, Sorrento Therapeutics 
  •  E. Sally Ward, Ph.D., Professor, Molecular and Cellular Medicine, Texas A&M Health Science Center 
  •  SiowFong Wee, Ph.D., Director, Formulation, Analytical & Bioassay, Aptevo Therapeutics 
  •  Stefan Weigand, Ph.D., Head, Large Molecule Research, Roche Innovation Center, Roche Pharma 
  •  Andrew Weinberg, Ph.D., Judy Ann Hartmann Endowed Chair for Cancer Immunology Research, Robert W. Franz Cancer Research Center 
  •  David Weiner, Ph.D., Vice President, Technology & Product Development, BASF Enzymes, LLC 
  •  James A. Wells, Ph.D., Professor, Pharmaceutical Chemistry, University of California, San Francisco 
  •  Tim Wenzel, Scientist, Ph.D. Candidate, University of Erlangen GILYOS GmbH 
  •  Ken Wong, Deputy Director, Process Technology, Sanofi Pasteur 
  •  Dongxin Zhao, Ph.D., Postdoctoral Fellow, Prashant Mali Lab, Department of Bioengineering, University of California, San Diego 
  •  Gregory A. Weiss, Ph.D., Professor, Chemistry and Molecular Biology & Biochemistry, University of California, Irvine 
  •  Jiansheng Wu, Ph.D., Principle Scientific Manager, Protein Chemistry, Genentech, Inc. 
  •  Zhen Wu, Ph.D., Senior Scientist, AbbVie 
  •  Noriko Yamano, Ph.D., Senior Scientist, Manufacturing Technology Association of Biologics; Guest Academic Staff, Graduate School of Engineering, Osaka University 
  •  Danlin Yang, Ph.D., Scientist, Biophysics, Biotherapeutics Discovery, Boehringer Ingelheim Pharmaceuticals 
  •  Alexei Yeliseev, Ph.D., Staff Scientist, LMBB, NIH/ NIAAA 
  •  Mimi Cho Yung, Ph.D., Biomedical Staff Scientist, Biosciences and Biotechnology Division, Lawrence Livermore National Laboratory 
  •  Alexandre Zanghellini, Ph.D., CEO, Arzeda 
  •  Qingchun Zhang, Ph.D., Senior Scientist, Amgen, Inc. 
  •  Wei Zhang, Ph.D., Mitacs Elevate Fellow, University of Toronto, Canada 
  •  Ali Zarrin, Ph.D., Senior Scientist, Immunology and Antibody Engineering, Genentech 
  •  Huiman Zhao, Ph.D., Departments of Chemical and Biomolecular Engineering, Chemistry, and Biochemistry, Bioengineering, Institute for Genomic Biology, and Center for Biophysics and Computational Biology, University of  Illinois 
  •  Haihong (Helen) Zhong, Ph.D., Senior Scientist, Oncology Research, MedImmune, Inc. 
  •  Qi (Tony) Zhou, Ph.D., Assistant Professor, Industrial and Physical Pharmacy, Purdue University 
  •  Kyle Zingaro, Ph.D., Development Scientist II, Early Stage Development, Alexion Pharmaceuticals 
  •  Jonathan Zmuda, Ph.D., Director, Cell Biology R&D, Thermo Fisher Scientific
  •  Zhongcheng Zou, Ph.D., Staff Scientist, Structural Immunology Section, Lab of Immunogenetics, NIAID/NIH